Page last updated: 2024-08-22

doxifluridine and Carcinosarcoma

doxifluridine has been researched along with Carcinosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choijamts, B; Emoto, M; Kawarabayashi, T; Miyamoto, S; Naganuma, Y; Nakajima, K; Ogata, S; Shirota, K	1

Other Studies

1 other study(ies) available for doxifluridine and Carcinosarcoma

Article	Year
Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts. Cancer science, 2011, Volume: 102, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cell Line, Tumor; Cyclohexanes; Endothelial Cells; Female; Floxuridine; Humans; Mice; Mice, Inbred BALB C; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Thrombospondin 1; Thymidine Phosphorylase; Uterine Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2011

Article

Year

Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.

Cancer science, 2011, Volume: 102, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cell Line, Tumor; Cyclohexanes; Endothelial Cells; Female; Floxuridine; Humans; Mice; Mice, Inbred BALB C; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Thrombospondin 1; Thymidine Phosphorylase; Uterine Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2011